Editorial: Perioperative chemotherapy for invasive bladder cancer - What should we tell our patients?

Journal of Urology

Volumn 155, Issue 4, 1996, Pages 1246-1247

  Raghavan, D ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; VINBLASTINE; ANTINEOPLASTIC AGENT; M VAC PROTOCOL; M-VAC PROTOCOL;

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; EDITORIAL; HUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; BLADDER TUMOR; COMPARATIVE STUDY; FEMALE; MALE; TECHNIQUE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; MALE; METHODS; METHOTREXATE; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0029985873     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66231-1     Document Type: Editorial

References (17)

1. Raghavan D. Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer Brit. J. Urol. 61 1988 1
2. Shearer R.J. Chilvers C.F. Bloom H.J. Bliss J.M. Horwich A. Babiker A. Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report Brit. J. Urol. 62 1988 558
3. Wallace D.M.A. Raghavan D. Kelly K.A. Sandeman T.F. Conn I.G. Teriana N. Dunn J. Boulas J. Latief T. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder Brit. J. Urol. 67 1991 608
4. Loehrer P.J. Sr. Einhorn L.H. Elson P.J. Crawford E.D. Kuebler P. Tannock I. Raghavan D. Stuart-Harris R. Sarosdy M.F. Lowe B.A. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J. Clin. Oncol. 10 1992 1066
5. Logothetis C.J. Dexeus F.H. Finn L. Sella A. Amato R.J. Ayala A.G. Kilbourn R.G. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors J. Clin. Oncol. 8 1990 1050
6. Meyers F.J. Palmer J.M. Freiha F.S. Harker E.G. Shortliffe L.D. Hannigan J. McWhirter K. Torti F.M. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study J. Urol. 134 1985 1118
7. Scher H.I. Yagoda A. Herr H.W. Sternberg C.N. Bosl G. Morse M.J. Sogani P.C. Watson R.C. Dershaw D.D. Reuter V. Geller N. Hollander P.S. Vaughan E.D. Jr. Whitmore W.F. Jr. Fair W.R. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion J. Urol. 139 1988 470
8. Schultz P.K. Herr H.W. Zhang Z.F. Bajorin D.F. Seidman A. Sarkis A. Fair W.R. Scherr D. Bosl G.J. Scher H.I. Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up J. Clin. Oncol. 12 1994 1394
9. Stockle M. Meyenburg W. Wellek S. Voges G. Gertenbach U. Thuroff J.W. Huber C. Hohenfellner R. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy Results of a controlled prospective study. J. Urol. 148 1992 302
10. Freiha F.S. Reese J. Torti F. Locally advanced bladder cancer treated with radical cystectomy and adjuvant chemotherapy. Results of a randomized prospective study J. Urol., part 2 151 1994 453A abstract 903
11. Kaufman D.S. Shipley W.U. Griffin P.P. Heney N.M. Althausen A.F. Efird J.T. Selective bladder preservation by combination treatment of invasive bladder cancer New Engl. J. Med. 329 1993 1377
12. Housset M. Maulard C. Chretien Y. Dufour B. Delanian S. Huart J. Colardelle F. Brunel P. Baillet F. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study J. Clin. Oncol. 11 1993 2150
13. Tester W. Porter A. Asbell S. Coughlin C. Heaney J. Krall J. Martz K. Venner P. Hammond E. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12 Int. J. Rad. Oncol. Biol. Phys. 25 1993 783
14. Coppin C. Gospodarowicz M. Dixon P. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or radical radiation Proc. Amer. Soc. Clin. Oncol. 11 1992 198
15. Levine E.G. Raghavan D. MVAC for bladder cancer: time to move forward again J. Clin. Oncol. 11 1993 387
16. Raghavan D. Shipley W.U. Garnick M.B. Russell P.J. Richie J.P. Biology and management of bladder cancer New Engl. J. Med. 322 1990 1129
17. Raghavan, D., Shipley, W. U., Hall, R. R. and Richie, J. P.: Management of invasive bladder cancer. In: Principles and Practice of Genitourinary Oncology. Edited by D. Raghavan, H. Scher, S. Leibel and P. H. Lange. Philadelphia: J. B. Lippincott Co., in press.